NYSE:BMYPharmaceuticals
Is Bristol Myers Squibb (BMY) Pricing In Its 2024 Results And Product Pipeline Outlook?
If you are wondering whether Bristol-Myers Squibb is offering good value at today’s price, you are not alone. This article is built to help you frame that question clearly.
The stock last closed at US$61.30, with returns of 2.6% over 7 days, 12.3% over 30 days, 14.7% year to date and 12.2% over 1 year, while the 3 year and 5 year figures are 1.3% and 23.1% respectively.
Recent coverage has focused on Bristol-Myers Squibb’s position as a large established pharmaceutical group, with investors...